All In Biotech

Drug Trial Radar · NCT06609239

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma

An Open Label Extension Study to Evaluate the Long-term Safety and Efficacy of Subcutaneous Lunsekimig in Adult Participants With Asthma Who Participated in Study DRI16762 or ACT18301

Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

900

Planned (sponsor's estimate)

Start

Sep 30, 2024

Primary completion

Jan 20, 2031

Study completion Jan 20, 2031

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Sep 24, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma who have previously completed the parent studies. After completion of the parent study, eligible participants will be offered the opportunity to participate in the long-term extension (LTE) study with lunsekimig. The study duration will be up to 148 weeks with a treatment duration being up to 144 weeks.

Conditions

  • Asthma

Interventions

  • LunsekimigDrug

    * Pharmaceutical form: Solution for injection in vial or pre-filled syringe (PFS) * Route of administration: Subcutaneous injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Exposure-adjusted incidence rate of treatment-emergent adverse event (TEAE), including adverse events of special interest (AESI), and serious adverse event (SAE)Time frame: From study baseline to week 148

Locations

150 sites in 21 countries. Site status is shown where the registry gives one.

  • Chandler Clinical Research Trials- Site Number : 8400075

    Chandler, Arizona

  • Tucson Clinical Research Institute- Site Number : 8400085

    Tucson, Arizona

  • Allianz Research Institute - Aurora- Site Number : 8400026

    Aurora, Colorado

  • Western States Clinical Research- Site Number : 8400014

    Wheat Ridge, Colorado

  • Helix Biomedics- Site Number : 8400114

    Boynton Beach, Florida

  • Beautiful Minds Clinical Research Center- Site Number : 8400049

    Cutler Bay, Florida

  • Qway Research - Hialeah- Site Number : 8400015

    Hialeah, Florida

  • Ilumina Medical Research- Site Number : 8400095

    Kissimmee, Florida

  • Clintex Research Group - Miami - Southwest 27th Avenue- Site Number : 8400048

    Miami, Florida

  • High Quality Research- Site Number : 8400039

    Miami, Florida

  • Innovations Biotech- Site Number : 8400040

    Miami, Florida

  • New Access Medical Center- Site Number : 8400043

    Miami, Florida

  • Deluxe Health Center- Site Number : 8400045

    Miami Lakes, Florida

  • Tellabio International Research Services- Site Number : 8400083

    Pembroke Pines, Florida

  • Alfa Medical Research LLC- Site Number : 8400146

    Pembroke Pines, Florida

  • Avanza Medical Research Center- Site Number : 8400135

    Pensacola, Florida

  • Windom Allergy, Asthma and Sinus Specialists- Site Number : 8400019

    Sarasota, Florida

  • Private Practice - Dr. David Kavtaradze- Site Number : 8400081

    Cordele, Georgia

  • Brigham & Women's Hospital- Site Number : 8400034

    Boston, Massachusetts

  • University of Michigan Health System - Ann Arbor- Site Number : 8400004

    Ann Arbor, Michigan

  • Midwest Clinical Research Center - St. Louis- Site Number : 8400006

    St Louis, Missouri

  • Tryon Medical Partners - Charlotte - Piedmont Row Drive South- Site Number : 8400029

    Charlotte, North Carolina

  • Asthma & Allergy Center - Toledo- Site Number : 8400017

    Toledo, Ohio

  • OK Clinical Research- Site Number : 8400021

    Edmond, Oklahoma

  • Clinical Research Associates of Central Pennsylvania- Site Number : 8400116

    DuBois, Pennsylvania

  • Allergy & Clinical Immunology Associates Pittsburgh- Site Number : 8400007

    Pittsburgh, Pennsylvania

  • Orion Clinical Research- Site Number : 8400001

    Austin, Texas

  • South Texas Medical Research Institute - TTS Research- Site Number : 8400010

    Boerne, Texas

  • Baylor University Medical Center- Site Number : 8400002

    Dallas, Texas

  • Western Sky Medical Research- Site Number : 8400023

    El Paso, Texas

  • Metroplex Pulmonary and Sleep Center- Site Number : 8400022

    McKinney, Texas

  • Investigational Site Number : 0320005

    Buenos Aires, Argentina

  • Investigational Site Number : 0320012

    Buenos Aires, Argentina

  • Investigational Site Number : 0320004

    Buenos Aires, Argentina

  • Investigational Site Number : 0320011

    Buenos Aires, Argentina

  • Investigational Site Number : 0320009

    Mendoza, Argentina

  • Investigational Site Number : 0320015

    Mendoza, Argentina

  • Investigational Site Number : 0320010

    Santa Fe, Argentina

  • Investigational Site Number : 0320007

    Berazategui, Buenos Aires, Argentina

  • Investigational Site Number : 0320003

    La Plata, Buenos Aires, Buenos Aires, Argentina

Showing 40 of 150 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.